美單日新增逾20萬宗新冠確診 七天日均死亡數字升至逾半年高
阿思達克 09-21 15:14
美國新冠疫情持續。據美國約翰霍普金斯大學，截至美國西岸時間午夜(本港時間下午3時)，美國累計新冠確診42,287,762宗，單日新增200,277宗。單日新增死亡個案2,310宗，累計676,075宗。
據美國衛生及公共服務部，美國目前有逾8.93萬人因新冠留醫。據約翰霍普金斯大學，過去七日每天有逾1,900人死於新冠，爲3月初以來最多。部分醫院要選擇性拯救病人，有醫院未能爲心臟停止跳動病人提供心肺復甦法，部分須入院病人要留家休息。
另外，美國藥廠輝瑞(PFE.US)將要求美國食品及藥物管理局批準「復必泰」於5至11歲小童使用，並稱臨牀測試顯示疫苗安全及有效。有專家預計美國當局在10月底至11月初批準該疫苗於5至11歲小童使用。
以下爲過去10日美國單日新增確診及死亡數字，每日截數時間爲美國西岸時間午夜：
日期│累計確診│單日新增確診│累計死亡│單日新增死亡
9月20日(一)│42,287,762宗│+200,277宗│676,075宗│+2,310宗
9月19日(日)│42,087,485宗│+ 36,733宗│673,765宗│+ 291宗
9月18日(六)│42,050,752宗│+ 56,897宗│673,474宗│+ 831宗
9月17日(五)│41,993,855宗│+207,876宗│672,643宗│+2,634宗
9月16日(四)│41,785,979宗│+249,364宗│670,009宗│+3,391宗
9月15日(三)│41,536,615宗│+171,360宗│666,618宗│+2,682宗
9月14日(二)│41,365,255宗│+143,983宗│663,936宗│+1,805宗
9月13日(一)│41,221,272宗│+266,014宗│662,131宗│+2,156宗
9月12日(日)│40,955,258宗│+ 33,767宗│659,975宗│+ 281宗
9月11日(六)│40,921,491宗│+ 57,444宗│659,694宗│+ 689宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
